Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (181-190 of 375) with videos related to

Pageof 38
Sort By:
Expert Opinion on Investigational Drugs|March 4, 2022
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancerElisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, et al.
Anticancer Research|June 4, 2020
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature ReviewPiero Fregatti, Marco Gipponi, Gabriele Zoppoli, et al.
Human Reproduction (Oxford, England)|April 9, 2024
Chemoprotection of the ovary: a leading role or a complementary strategy in fertility preservation?Claudia Massarotti, Omar F Ammar, George Liperis, et al.
Cancer Treatment Reviews|May 27, 2022
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedsideIcro Meattini, Lorenzo Livi, Nicla Lorito, et al.
Seminars in Oncology|April 15, 2025
Liquid biopsy: An innovative tool in oncology. Where do we stand?Serafina Martella, Demi Wekking, Eleonora Lai, et al.
Critical Reviews in Oncology/Hematology|May 13, 2026
The prognostic impact of pregnancy-associated melanoma on overall and melanoma-specific survival: a systematic review and meta-analysisDimitrios Stylianakis, Cinzia Solinas, Fausto Petrelli, et al.
ESMO Open|May 9, 2020
Call for ensuring cancer care continuity during COVID-19 pandemicMarco Tagliamento, Matteo Lambertini, Carlo Genova, et al.
ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with <i>BRCA</i>-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.
Breast Cancer (Dove Medical Press)|June 3, 2021
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal WomenValentino Martelli, Maria Maddalena Latocca, Tommaso Ruelle, et al.
Anticancer Research|July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancerAlessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.
Pageof 38

Showing results (181-190 of 375) with videos related to

Sort By:
Pageof 38
Expert Opinion on Investigational Drugs|March 4, 2022
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancerElisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, et al.
Anticancer Research|June 4, 2020
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature ReviewPiero Fregatti, Marco Gipponi, Gabriele Zoppoli, et al.
Human Reproduction (Oxford, England)|April 9, 2024
Chemoprotection of the ovary: a leading role or a complementary strategy in fertility preservation?Claudia Massarotti, Omar F Ammar, George Liperis, et al.
Cancer Treatment Reviews|May 27, 2022
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedsideIcro Meattini, Lorenzo Livi, Nicla Lorito, et al.
Seminars in Oncology|April 15, 2025
Liquid biopsy: An innovative tool in oncology. Where do we stand?Serafina Martella, Demi Wekking, Eleonora Lai, et al.
Critical Reviews in Oncology/Hematology|May 13, 2026
The prognostic impact of pregnancy-associated melanoma on overall and melanoma-specific survival: a systematic review and meta-analysisDimitrios Stylianakis, Cinzia Solinas, Fausto Petrelli, et al.
ESMO Open|May 9, 2020
Call for ensuring cancer care continuity during COVID-19 pandemicMarco Tagliamento, Matteo Lambertini, Carlo Genova, et al.
ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with <i>BRCA</i>-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.
Breast Cancer (Dove Medical Press)|June 3, 2021
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal WomenValentino Martelli, Maria Maddalena Latocca, Tommaso Ruelle, et al.
Anticancer Research|July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancerAlessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.
Pageof 38